Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

AI Briefing

• – Revenue increases 14% to $133.9M, delivers positive net income and adjusted EBITDA, and reports $17.3M in total cash.
• – Xtant receives an additional $10.5M in cash subsequent to year-end
• – Full-year results show significant growth and financial stability